Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 33 - Medicinal preparations containing inorganic active ingredients
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
05/2005
05/18/2005CN1617755A Fpt inhibitor and use of other anti-tumor agent in combination in preparing anticancer drug
05/18/2005CN1617711A Liposomal delivery of vitamin E based compounds
05/18/2005CN1616059A Medicinal composition for treating burn and scald and preparing method
05/18/2005CN1615908A Absorbent for oral administration, and agent for treating or preventing renal or liver disease
05/18/2005CN1615907A Carbon gas gel transfusion agent, its preparing method and its use
05/18/2005CN1615906A 18 compound amino acid injection and its preparing method
05/18/2005CN1615905A White arsenic local slow release chemical therapeutic medicine for treating malignant brain tumor
05/18/2005CN1615904A Process for preparing white arsenic nano particles
05/18/2005CN1615903A Virus medicine for silk worm
05/18/2005CN1202130C Solid, stable and concentrated type ortho-silicis acid complex based on bio-absorption, and its prepn. method
05/18/2005CN1201809C Preparation of Chinese herbal medicine for removal of urinary calculus
05/18/2005CN1201806C Medicine for curing cardiac premature beat
05/18/2005CN1201791C External plaster for treating rheumatic arthralgia and its preparing method
05/18/2005CN1201779C Medicine for curing setting of fracture
05/18/2005CN1201762C A medicine for treating scald and burn, and method for preparing same
05/18/2005CN1201758C Chinese medicine for treating silicosis
05/18/2005CN1201750C Oculentum for treating eye disease and preparing method thereof
05/18/2005CN1201723C Skin and tissue care and/or treatment agent and its use
05/18/2005CN1201722C Effect improved anhidrotic emulsion containing fine aluminum and zirconium powders, and preparing method thereof
05/17/2005US6894030 Treatment of DNA viral infections
05/12/2005WO2005042142A2 Thermosensitive, biocompatible polymer carriers with a variable physical structure for treatment, diagnosis and analysis
05/12/2005WO2005042002A2 Treatment of rhematoid arthritis with flip antagonists
05/12/2005WO2005041989A1 Topical agent and use of potassium antimonyl tartrate for preparing said agent
05/12/2005WO2005041955A1 Methods for treating non-microbial inflammatory skin conditions
05/12/2005WO2005041944A2 Methods and compositions for promoting axon regeneration and cell replacement therapy
05/12/2005WO2005041928A1 Compositions and dosage forms for ehnanced absorption of iron
05/12/2005WO2005041927A1 Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
05/12/2005WO2005041926A1 Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid
05/12/2005WO2005041925A2 Compositions and dosage forms for enhanced absorption
05/12/2005WO2005041924A2 Administration of levodopa and carbidopa
05/12/2005WO2005041923A1 Compositions and dosage forms for enhanced absorption of metformin
05/12/2005WO2005041913A1 Textile and footwear products treated with sulfur
05/12/2005WO2005041889A2 Personal care composition containing a detersive surfactant, an antidandruff component, and ketoamide surfactants
05/12/2005WO2005041660A1 Antimicrobial composites, films, labelstocks and labels
05/12/2005WO2005041657A1 Zeolite molecular sieves for the removal of toxins
05/12/2005WO2005041656A2 Methods, compositions and devices for inducing stasis in tissues and organs
05/12/2005WO2005041655A1 Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
05/12/2005WO2004105682A3 Carbostyril derivatives and mood stabilizers for treating mood disorders
05/12/2005US20050101691 Anti-microbial tool grip
05/12/2005US20050101635 Delivering to an external portion of the body passageway of a patient in need of a therapeutically effective amount of an antihistamine or decongestant to treat inflammatory diseases
05/12/2005US20050101571 Methods of treating cancer using a combination of drugs
05/12/2005US20050101524 Using arsenic oxide, or complex thereof; angiogenesis inhibitors; anticarcinogenic agents; neurodegenerative agents; antiischemic agents
05/12/2005US20050100643 Introducing into water with which poultry carcasses or parts are washed after slaughtering, microbiocidal amount of 1,3-dibromo-5,5-dialkylhydantoin in which one alkyl group is methyl and other contains 1 to 4 carbon atoms
05/12/2005US20050100637 Carbohydrate and electrolyte replacement composition
05/12/2005US20050100620 Compositions of oak bark extract, related synthetic compositions, and method of using same
05/12/2005US20050100615 controling metabolic acidosis due to burn injury, hemorrhagic shock, multiple organ failure, systemic inflammatory response syndrome (SIRS); administering sodium bicarbonate
05/12/2005US20050100614 Chromium bound to niacin and three compounds from the group consisting of (-) hydroxycitric acid, zinc (particularly zinc methionine), trans-reseveratrol, gymnernic acid, selenium, an anthocyanidin, allicin, and fenugreek.
05/12/2005US20050100612 Virucidal activities of cetylpyridinium chloride
05/12/2005US20050100611 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors
05/12/2005US20050100601 Virucidal activities of cetylpyridinium chloride
05/12/2005US20050100593 Of gelatin and polyglutamic acid; inhibits an insolubilization phenomenon in the film that occurs during storage of the gelatin capsule; improves bioavailability of mineral ingredients such as calcium or iron
05/12/2005US20050100571 Applying a cosmetic preparation to the skin, and applying an occlusive material to the skin such as a silicone
05/12/2005US20050100563 Tin oxyfluoride or other transition metal halides in aqueous solution produce mild hydrohalo acid; topical application to affected skin and nails
05/12/2005US20050100538 Intradiscal injection of anti-oxidants
05/12/2005CA2543945A1 Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid
05/12/2005CA2543512A1 Textile and footwear products treated with sulfur
05/12/2005CA2543496A1 Antimicrobial composites, films, labelstocks and labels
05/12/2005CA2543238A1 Compositions and dosage forms for enhanced absorption
05/12/2005CA2543227A1 Administration of levodopa and carbidopa
05/12/2005CA2543198A1 Personal care composition containing a detersive surfactant, an antidandruff component, and ketoamide surfactants
05/12/2005CA2543185A1 Compositions and dosage forms for ehnanced absorption of iron
05/12/2005CA2543181A1 Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
05/12/2005CA2543177A1 Compositions and dosage forms for enhanced absorption of metformin
05/12/2005CA2542968A1 Zeolite molecular sieves for the removal of toxins
05/12/2005CA2542861A1 Methods for treating non-microbial inflammatory skin conditions
05/12/2005CA2542810A1 Methods, compositions and devices for inducing stasis in tissues and organs
05/12/2005CA2542806A1 Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
05/11/2005EP1529784A1 Polymeric anhydride of magnesium and proteic ammonium phospholinoleate-palmitoleate.
05/11/2005EP1529015A2 Rare earth metal compounds, methods of making, and methods of using the same
05/11/2005EP1528894A2 Biomatrix structural containment and fixation systems and methods of use thereof
05/11/2005EP1315480B1 "slow release" pharmaceutical compositions comprising lithium carbonate
05/11/2005EP1083931B1 Stabilization of compositions containing ace inhibitors using magnesium oxide
05/11/2005CN1615159A Preparation for wound healing and prevention of bandage adhesion to the wound
05/11/2005CN1615153A Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
05/11/2005CN1615152A Method for reducing acne or improving skin tone
05/11/2005CN1615128A Preparation for improving the action of receptors
05/11/2005CN1200742C System and compositions used in perfusion applications
05/11/2005CN1200724C Pill for activating collateral flow and removing spur
05/11/2005CN1200720C Ointment for treating burn and its preparing process
05/11/2005CN1200717C External use burn treating medicine and its preparation
05/11/2005CN1200706C Compositions and methods for treating or preventing inflammatory diseases
05/11/2005CN1200684C Compositions comprising organosiloxane resins for delivering oral care substances
05/10/2005US6890953 Using silver citrate
05/10/2005US6890568 Method for management of blood glucose levels
05/10/2005US6890550 Method of preventing parturient hypocalcemia in animals and compositions used therein
05/10/2005US6890457 Infrared radiation emitting ceramic powders comprising zirconium or radium and oxides of silicon, aluminum, iron, titanium, calcium, magnesium, potassium and sodium, used for joining wood, paper, leather, metals or plastics; radiotherapy
05/06/2005WO2005039648A2 Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents
05/06/2005WO2005039605A1 Pharmaceutical composition comprising oxoplatin, the salts and derivatives thereof
05/06/2005WO2005039604A1 Nutrition trace element composition
05/06/2005WO2005039603A1 Combined preparation for treating sepsis
05/06/2005WO2005039602A1 Pharmacologically functional water and use thereof
05/06/2005WO2005039601A1 Anticancer drug from deep sea water
05/06/2005WO2005039600A2 Use of xenon for the prevention of programmed cell death
05/06/2005WO2005039557A1 Use of selected amino acid-zinc complexes as anti-malarial
05/06/2005WO2005039493A2 Herbal composition for weight control
05/06/2005WO2005039485A2 Gsk-3 inhibitors and uses thereof
05/06/2005WO2005039320A2 Composition for the activation of the immune system
05/06/2005WO2005039291A2 Methods, compositions and devices for inducing stasis in cells
05/06/2005WO2005011711A3 Inhalable gaseous medicine based on xenon and nitrous oxide
05/06/2005WO2004032823A8 Treatment and rehydration composition which is used to limit the side effects of gastro-enteritis in adults
1 ... 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 ... 563